Phase 1, Two-Part, Multicenter, Non-randomized, Open-label, Multiple Dose First-In-Human Study of DS-8201A, in Subjects With Advanced Solid Malignant Tumors
收藏DataCite Commons2025-06-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007149/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is an open-label, two-part, multiple study to evaluate the safety and tolerability of
DS-8201a in patients with advanced solid malignant tumors.
提供机构：
Vivli
创建时间：
2021-05-24
